Evidence-Based Criteria for Sarcopenia with Clinically Important Weakness
- 15 September 2012
- journal article
- editorial
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 42 (4) , 447-449
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- Considerations in the Development of Drugs to Treat SarcopeniaJournal of the American Geriatrics Society, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Epidemiology and consequences of sarcopeniaThe Journal of nutrition, health and aging, 2009
- Strength, But Not Muscle Mass, Is Associated With Mortality in the Health, Aging and Body Composition Study CohortThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2006
- Influence of Sarcopenia on the Development of Physical Disability: The Cardiovascular Health StudyJournal of the American Geriatrics Society, 2005
- Muscle Mass, Muscle Strength, and Muscle Fat Infiltration as Predictors of Incident Mobility Limitations in Well-Functioning Older PersonsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2005
- Skeletal Muscle Mass and Muscle Strength in Relation to Lower‐Extremity Performance in Older Men and WomenJournal of the American Geriatrics Society, 2000